Status:
TERMINATED
Feasibility of Partners in Care Program for Caregivers of Patients With Acute Myeloid Leukemia
Lead Sponsor:
University of Washington
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
18-82 years
Phase:
NA
Brief Summary
This trial studies the feasibility of delivering the Partners in Care Program to caregivers of patients with acute myeloid leukemia. Psychological counseling interventions, such as the Partners in Car...
Detailed Description
OUTLINE: Participants are randomized to 1 of 2 groups. GROUP A: Participants attend 5 psychoeducational counseling sessions over 30-60 minutes via telephone. GROUP B: Participants attend 5 psychoedu...
Eligibility Criteria
Inclusion
- Diagnosis of AML within the recent 2 months
- Caregivers and patients need to write, read, and speak English as one of their languages of choice; and currently sharing a residence at least 50% of the time together
- Patient must have no other concurrent cancer diagnosis except for basal or squamous cell
- Caregiver must be able to sustain up to 60 minutes of interaction with patient educator
- Ability to understand and the willingness to sign a written informed consent document
Exclusion
- Participants will be excluded if either the patient or the caregiver cannot write, read, and speak English as one of their languages of choice; are not currently sharing a residence at least 50% of the time together
- The patient cannot have another concurrent cancer diagnosis except for basal or squamous cell
- Caregiver cannot sustain up to 60 minutes of interaction with the patient educator
- Caregiver does not have access to a computer with 2-way video capability (i.e. ZOOM) or a cell phone
Key Trial Info
Start Date :
March 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03806192
Start Date
March 16 2019
End Date
November 30 2020
Last Update
June 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109